Volume 11,Issue 1
Discussion on the Immunologic Mechanism of Zhuang Medicine External Treatment of Allergic Rhinitis Based on the Theory of “Disease Caused by Toxin-Deficiency”
Allergic rhinitis (AR) is an IgE-mediated Th2-type inflammatory disease of the nasal mucosa. It has a a high prevalence worldwide and significantly affects patients’ quality of life. Currently, Western medicine treatment can control symptoms, however, it still faces issues such as recurrence and long-term medication. Zhuang medicine, based on the theory of “disease caused by toxin-deficiency”, emphasizes the interaction and mutual influence of “toxin” and “deficiency” in causing the disease. This article holds that the occurrence and development of AR reflect the pathological dynamics and evolution of “toxin” and “deficiency”, which are reciprocally mutually causa. Based on the theory, Zhuang medicine external treatment, guided by the principles of “detoxifying and tonifying deficiency, unblocking pathways and regulating Qi”, demonstrate unique advantages in the clinical management of AR. This article aims to clarify the intrinsic connection between the “theory of disease caused by toxin-deficiency” and modern pathogenesis of AR, and systematically elucidate the mechanism and clinical application of the Zhuang medicine external treatment, hoping to provide innovative theoretical perspective and practical evidence based on the ethnic medical theory for the prevention and treatment of AR through integrated Chinese and Western medicine.
[1] Gu Y, Li H, 2022, Interpretation of Chinese Guidelines for Diagnosis and Treatment of Allergic Rhinitis (2022 Revised Edition). Chinese Journal of Otorhinolaryngology, 22(2): 209–211.
[2] Yang Z, Chen X, Zhang X, 2023, The Role of Micro-RNA in Allergic Rhinitis and Its Research Progress. Chinese Journal of Otolaryngology and Skull Base Surgery, 29(1): 123–128.
[3] Cheng L, Chen J, Fu Q, et al., 2018, Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis. Allergy, Asthma & Immunology Research, 10(4): 300.
[4] Wang X, Zheng M, Lou H, et al., 2016, An Increased Prevalence of Self-Reported Allergic Rhinitis in Major Chinese Cities from 2005 to 2011. Allergy, 71(8): 1170–1180.
[5] Sharma K, Akre S, Chakole S, et al., 2022, Allergic Rhinitis and Treatment Modalities: A Review of Literature. Cureus, 14(8): e28501.
[6] Pu C, Lan Y, 2023, A Review of Research in Toxin-Deficiency Pathogenesis Theory in Zhuang Medicine. Guiding Journal of Traditional Chinese Medicine and Pharmacy, 29(5): 71–75.
[7] Huang A, Pang Y, 2020, An Overview of Toxin Theory, Toxin Disease, and Therapeutic Characteristics in Zhuang Medicine. Guangxi Journal of Traditional Chinese Medicine, 43(6): 28–30.
[8] Li Z, Wang Y, Chi J, et al., 2023, Research Progress on Pollen Protein Hydrolase in the Mucosal Barrier and Inflammatory Pathways of Allergic Rhinitis. Journal of Hebei North University (Natural Science Edition), 39(2): 57–60 + 65.
[9] Wang W, 2012, Correlation Analysis of House Dust Mite Nasal Provocation Test with Sensitization Status and Quality of Life, and Its Impact on Upper and Lower Airway Inflammation in Allergic Rhinitis, thesis, Guangzhou Medical University.
[10] Sun J, Chen J, 2004, Research Progress on House Dust Mite Control Methods. International Journal of Respiration, 2004(1): 47–50.
[11] Hu M, 2015, Study on the Separation of Chemical Constituents and Anti-inflammatory Activity of Rhizoma Smilacis Glabrae, thesis, Guangzhou University of Chinese Medicine.
[12] Zuo A, Rao G, 2014, Research Progress on the Chemical Constituents and Pharmacological Effects of Herba Elephantopus. China Pharmaceuticals, 23(17): 3–7.
[13] Wang B, Zhao J, Zhang Y, et al., 2019, Research Progress on the Pharmacological Effects of Herba Bidentis Bipinnatae. Guiding Journal of Traditional Chinese Medicine and Pharmacy, 25(18): 100–103 + 107.
[14] Pang Y, Lin C, Huang D, 2006, Introduction to Zhuang Medicine. Guangxi Nationalities Publishing House: 184.
[15] Goleva E, Berdyshev E, Leung D, 2019, Epithelial Barrier Repair and Prevention of Allergy. Journal of Clinical Investigation, 129(4): 1463–1474.
[16] Pazgier M, Hoover D, Yang D, et al., 2006, Human β-Defensins. Cellular and Molecular Life Sciences, 63(11): 1294–1313.
[17] Zheng B, Wang M, Zeng Y, et al., 2016, Observation on the Effect of Subcutaneous Immunotherapy on Serum Human Beta-Defensin-2 Levels in Children with Allergic Rhinitis. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 23(10): 565–568.
[18] Zhu X, Hu X, Yu T, et al., 2013, Research Progress on Interleukin-Type Antiviral Cytokines. Current Immunology, 33(6): 522–526.
[19] Fu W, Xie H, Xiong D, 2010, Active Expression of Interleukin mRNA in the Nasal Mucosa of Rats with Spleen Deficiency-Type Allergic Rhinitis. Chinese Archives of Traditional Chinese Medicine, 28(12): 2486–2489.
[20] Sun Y, Sun L, Wang Z, et al., 2022, Study on Differential Expression of TNF-α, IFN-γ, and IL-10 in Salivary Glands of Rats with Kidney Deficiency and Spleen Deficiency. Acta Chinese Medicine, 37(7): 1491–1495.
[21] Lu J, Peng Z, Zheng L, 2018, Clinical Observation of Medicated Thread Moxibustion Combined with Electroacupuncture in Treating Allergic Rhinitis. Liaoning Journal of Chinese Medicine, 45(11): 2415–2418.
[22] Wang X, Jiang J, Cui L, et al., 2007, Clinical Observation of Zhuang Medicine Medicated Thread Moxibustion Combined with Acupoint Application During Sanfu Days for Treating Allergic Rhinitis. Journal of Sichuan Traditional Chinese Medicine, 2007(10): 116–117.
[23] Li H, Ruan H, Zhang J, et al., 2023, Fifty-Two Cases of Allergic Rhinitis with Lung Qi Deficiency Treated with Qidi Buxu Formula Combined with Medicated Thread Moxibustion. Global Traditional Chinese Medicine, 16(8): 1668–1671.
[24] Zhang Y, Zhao K, Wushanshan, et al., 2023, Clinical Efficacy and Immune Function Impact of Zhuang Medicine Medicated Thread Moxibustion on Subacute Eczema. Journal of External Therapy of Traditional Chinese Medicine, 32(5): 23–26.
[25] Huang H, 1996, Overview of the Theoretical System of Zhuang Medicine. Journal of Basic Chinese Medicine, 1996(6): 3–7.
[26] Lin C, Huang H, Xue L, 2012, Discussion on the Basic Characteristics and Core Theories of Zhuang Medicine. Journal of Basic Chinese Medicine, 18(11): 1205–1206.
[27] Gui X, Li Z, Wei W, 2020, Clinical Efficacy of Zhuang Medicine Lotus Needle Cupping and Stasis-Removing Therapy in Treating Allergic Rhinitis. Journal of Practical Traditional Chinese Medicine, 36(1): 99–100.
[28] Liu C, Zhang L, Han D, 2009, Detection of Specific IgE and Its Application in the Diagnosis of Allergic Diseases. Journal of Clinical Otorhinolaryngology Head and Neck Surgery, 23(2): 88–92.
[29] Wang L, Feng W, 2015, Effect of Zhuang Medicine Lotus Needle Back Cupping Therapy on Serum Th1/Th2 Cell Balance in Patients with Allergic Rhinitis. Guangxi Journal of Traditional Chinese Medicine, 38(4): 59–61.
[30] Liao X, Li F, 2019, Clinical Application of Zhuang Medicine Pricking Therapy. Guangxi Medical Journal, 41(12): 1559–1561.
[31] Chen Y, Lv L, Chen H, et al., 2000, Effect of Acupoint Pricking on the Nasal Mucosal Histamine Challenge Threshold in Experimental Allergic Rhinitis. Chinese Acupuncture & Moxibustion, 2000(2): 51–53 + 4.
[32] Chen Y, Lv L, Chen H, et al., 2005, Observation on the Efficacy of Different Acupoint Pricking Prescriptions in Treating Seasonal Allergic Rhinitis in Zhuang Medicine. Proceedings of the First National Academic Conference on Zhuang Medicine and the National Conference on Ethnic Medicine Experience Exchange. Nanjing: 152–154.
[33] Chen Y, Wu L, Li F, et al., 1998, Clinical Study of Acupoint Pricking in Treating Thirty-One Cases of Allergic Rhinitis. Chinese Acupuncture & Moxibustion, 1998(8): 5–7 + 4.
[34] Chen Y, Lv L, Chen H, et al., 2003, Effect of Acupoint Pricking Therapy on IL-4 and Total Serum IgE in Experimental Allergic Rhinitis. Guangxi Journal of Traditional Chinese Medicine, 2003(1): 48–51.